2-(2-((tert-Butoxycarbonyl)amino)-N-methylacetamido)acetic acid, 97%, 250mg

(2,2-DIFLUORO-HEXAHYDRO-1H-PYRROLIZIN-7A-YL)METHANOL, 95%, 5g

4-azidobutan-1-ol, 250mg

4-Isopropyl-1,1'-biphenyl, 98%, 25g

6,7-Dichloroquinoxaline-2,3(1H,4H)-dione, 95.0%, 1g

5-(chloromethyl)-N-methyl-1,2,4-oxadiazole-3-carboxamide, 95.0%, 1g

Balance d'analyse et de précision Série Entris® II Modèles avec réglage interne, non certifiés, 0,001 g, 620 g, BCE623i-1S (W)

(R)-2-((tert-butoxycarbonyl)amino)-2-cyclobutylacetic acid, 97%, 1g

3'-FLUORO-3'-DEOXYADENOSINE, 95.0%, 50mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,2-diamine, 97%, 100mg

5,7-dichloro-2H-[1,2,3]triazolo[4,5-b]pyridine, 95%, 250mg

N-Methylformamide>99.0%(GC)500g

5-Chloro-2-ethynylbenzaldehyde, 97%, 1g